GCT SEMICONDUCTOR HOLDING IN (GCTS) Fundamental Analysis & Valuation

NYSE:GCTSUS36170N1072

Current stock price

1.29 USD
0 (0%)
At close:
1.28 USD
-0.01 (-0.78%)
After Hours:

This GCTS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. GCTS Profitability Analysis

1.1 Basic Checks

  • GCTS had negative earnings in the past year.
  • In the past year GCTS has reported a negative cash flow from operations.
  • In multiple years GCTS reported negative net income over the last 5 years.
  • GCTS had a negative operating cash flow in each of the past 5 years.
GCTS Yearly Net Income VS EBIT VS OCF VS FCFGCTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 20M -20M -40M

1.2 Ratios

  • GCTS has a worse Return On Assets (-277.24%) than 94.78% of its industry peers.
Industry RankSector Rank
ROA -277.24%
ROE N/A
ROIC N/A
ROA(3y)-158.74%
ROA(5y)-93.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GCTS Yearly ROA, ROE, ROICGCTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 -100 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for GCTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GCTS Yearly Profit, Operating, Gross MarginsGCTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

0

2. GCTS Health Analysis

2.1 Basic Checks

  • GCTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for GCTS has been increased compared to 1 year ago.
  • GCTS has a worse debt/assets ratio than last year.
GCTS Yearly Shares OutstandingGCTS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
GCTS Yearly Total Debt VS Total AssetsGCTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -66.33, we must say that GCTS is in the distress zone and has some risk of bankruptcy.
  • GCTS has a worse Altman-Z score (-66.33) than 86.96% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -66.33
ROIC/WACCN/A
WACC12.76%
GCTS Yearly LT Debt VS Equity VS FCFGCTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 0.15 indicates that GCTS may have some problems paying its short term obligations.
  • GCTS's Current ratio of 0.15 is on the low side compared to the rest of the industry. GCTS is outperformed by 97.39% of its industry peers.
  • GCTS has a Quick Ratio of 0.15. This is a bad value and indicates that GCTS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of GCTS (0.14) is worse than 97.39% of its industry peers.
Industry RankSector Rank
Current Ratio 0.15
Quick Ratio 0.14
GCTS Yearly Current Assets VS Current LiabilitesGCTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

3

3. GCTS Growth Analysis

3.1 Past

  • The earnings per share for GCTS have decreased strongly by -206.83% in the last year.
  • GCTS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -68.60%.
EPS 1Y (TTM)-206.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-45.45%
Revenue 1Y (TTM)-68.6%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-57.54%

3.2 Future

  • Based on estimates for the next years, GCTS will show a very strong growth in Earnings Per Share. The EPS will grow by 34.77% on average per year.
  • The Revenue is expected to grow by 281.10% on average over the next years. This is a very strong growth
EPS Next Y30.76%
EPS Next 2Y34.66%
EPS Next 3Y34.77%
EPS Next 5YN/A
Revenue Next Year950.75%
Revenue Next 2Y402.48%
Revenue Next 3Y281.1%
Revenue Next 5YN/A

3.3 Evolution

GCTS Yearly Revenue VS EstimatesGCTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 50M 100M 150M
GCTS Yearly EPS VS EstimatesGCTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4 -0.6 -0.8

1

4. GCTS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GCTS. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GCTS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GCTS Price Earnings VS Forward Price EarningsGCTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GCTS Per share dataGCTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

  • GCTS's earnings are expected to grow with 34.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.66%
EPS Next 3Y34.77%

0

5. GCTS Dividend Analysis

5.1 Amount

  • GCTS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

GCTS Fundamentals: All Metrics, Ratios and Statistics

GCT SEMICONDUCTOR HOLDING IN

NYSE:GCTS (4/10/2026, 8:27:04 PM)

After market: 1.28 -0.01 (-0.78%)

1.29

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)03-25
Earnings (Next)05-12
Inst Owners13.82%
Inst Owner Change0%
Ins Owners4.82%
Ins Owner Change2.76%
Market Cap93.49M
Revenue(TTM)2.87M
Net Income(TTM)-43.37M
Analysts82.5
Price Target3.91 (203.1%)
Short Float %3.55%
Short Ratio0.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.38%
Min EPS beat(2)-29%
Max EPS beat(2)29.76%
EPS beat(4)1
Avg EPS beat(4)-32.09%
Min EPS beat(4)-82.07%
Max EPS beat(4)29.76%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-44.18%
Min Revenue beat(2)-64.52%
Max Revenue beat(2)-23.83%
Revenue beat(4)0
Avg Revenue beat(4)-53%
Min Revenue beat(4)-74.04%
Max Revenue beat(4)-23.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.52%
EPS NQ rev (1m)22.81%
EPS NQ rev (3m)22.81%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.14%
Revenue NQ rev (1m)-35.11%
Revenue NQ rev (3m)-41.75%
Revenue NY rev (1m)-21.54%
Revenue NY rev (3m)-21.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 32.62
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.82
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS0.04
BVpS-1.15
TBVpS-1.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -277.24%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-158.74%
ROA(5y)-93.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 324.06%
Cap/Sales 84.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.15
Quick Ratio 0.14
Altman-Z -66.33
F-Score1
WACC12.76%
ROIC/WACCN/A
Cap/Depr(3y)144.42%
Cap/Depr(5y)N/A
Cap/Sales(3y)30.71%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-206.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-45.45%
EPS Next Y30.76%
EPS Next 2Y34.66%
EPS Next 3Y34.77%
EPS Next 5YN/A
Revenue 1Y (TTM)-68.6%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-57.54%
Revenue Next Year950.75%
Revenue Next 2Y402.48%
Revenue Next 3Y281.1%
Revenue Next 5YN/A
EBIT growth 1Y-35.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.17%
EBIT Next 3Y42.13%
EBIT Next 5YN/A
FCF growth 1Y-5.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.91%
OCF growth 3YN/A
OCF growth 5YN/A

GCT SEMICONDUCTOR HOLDING IN / GCTS Fundamental Analysis FAQ

What is the fundamental rating for GCTS stock?

ChartMill assigns a fundamental rating of 1 / 10 to GCTS.


Can you provide the valuation status for GCT SEMICONDUCTOR HOLDING IN?

ChartMill assigns a valuation rating of 1 / 10 to GCT SEMICONDUCTOR HOLDING IN (GCTS). This can be considered as Overvalued.


Can you provide the profitability details for GCT SEMICONDUCTOR HOLDING IN?

GCT SEMICONDUCTOR HOLDING IN (GCTS) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for GCTS stock?

The Earnings per Share (EPS) of GCT SEMICONDUCTOR HOLDING IN (GCTS) is expected to grow by 30.76% in the next year.